Cardama Alfonso Quintas has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 300000 shares of Foghorn Therapeutics Inc. ($FHTX) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Foghorn Therapeutics Inc. | $FHTX | Cardama Alfonso Quintas | Chief Medical Officer | A | Stock option (right to buy) | 300000 | $5.71 | 300,000.0000 | 63,029,293 | 9999.99% | 0.48% |
| Jan. 22, 2025 | Foghorn Therapeutics Inc. | $FHTX | Cardama Alfonso Quintas | Chief Medical Officer | A | Stock Option (right to buy) | 125000 | $4.37 | 125,000.0000 | 54,899,432 | 9999.99% | 0.23% |
| Jan. 24, 2024 | Foghorn Therapeutics Inc. | $FHTX | Cardama Alfonso Quintas | Chief Medical Officer | A | Stock Option (right to buy) | 60000 | $3.06 | 60,000.0000 | 41,974,484 | 9999.99% | 0.14% |